| Dr Magdalena Lucia Bak, OD | |
|
1402 Butterfield Rd, Downers Grove, IL 60515-1031 | |
| (630) 424-0613 | |
| Not Available |
| Full Name | Dr Magdalena Lucia Bak |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 14 Years |
| Location | 1402 Butterfield Rd, Downers Grove, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184938227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 046010340 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rosley Eyecare And Associates Llc | 8426456674 | 2 |
| Eye Level Inc | 9830221977 | 2 |
News Archive
American Well™ has been honored as one of the Most Innovative Companies in Healthcare by Fast Company in its annual Most Innovative Companies issue. American Well was recognized for extending Online Care to consumers and physicians nationwide in partnership with top health plans and delivery networks. Other leaders on Fast Company's list include Google, Cisco, Apple and GE, along with such rising newcomers as Twitter and Gilt Groupe.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.
Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.
› Verified 5 days ago
| Provider Name | Ageless Eye Care Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962637439 PECOS PAC ID: 9638211253 Enrollment ID: O20100120000617 |
News Archive
American Well™ has been honored as one of the Most Innovative Companies in Healthcare by Fast Company in its annual Most Innovative Companies issue. American Well was recognized for extending Online Care to consumers and physicians nationwide in partnership with top health plans and delivery networks. Other leaders on Fast Company's list include Google, Cisco, Apple and GE, along with such rising newcomers as Twitter and Gilt Groupe.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.
Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.
› Verified 5 days ago
| Provider Name | Eye Level Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225240369 PECOS PAC ID: 9830221977 Enrollment ID: O20100724000275 |
News Archive
American Well™ has been honored as one of the Most Innovative Companies in Healthcare by Fast Company in its annual Most Innovative Companies issue. American Well was recognized for extending Online Care to consumers and physicians nationwide in partnership with top health plans and delivery networks. Other leaders on Fast Company's list include Google, Cisco, Apple and GE, along with such rising newcomers as Twitter and Gilt Groupe.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.
Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.
› Verified 5 days ago
| Provider Name | Rosley Eyecare And Associates Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1578238978 PECOS PAC ID: 8426456674 Enrollment ID: O20211001002746 |
News Archive
American Well™ has been honored as one of the Most Innovative Companies in Healthcare by Fast Company in its annual Most Innovative Companies issue. American Well was recognized for extending Online Care to consumers and physicians nationwide in partnership with top health plans and delivery networks. Other leaders on Fast Company's list include Google, Cisco, Apple and GE, along with such rising newcomers as Twitter and Gilt Groupe.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.
Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Magdalena Lucia Bak, OD 3446 N Seminary Ave, #2, Chicago, IL 60657-1533 Ph: (773) 343-0212 | Dr Magdalena Lucia Bak, OD 1402 Butterfield Rd, Downers Grove, IL 60515-1031 Ph: (630) 424-0613 |
News Archive
American Well™ has been honored as one of the Most Innovative Companies in Healthcare by Fast Company in its annual Most Innovative Companies issue. American Well was recognized for extending Online Care to consumers and physicians nationwide in partnership with top health plans and delivery networks. Other leaders on Fast Company's list include Google, Cisco, Apple and GE, along with such rising newcomers as Twitter and Gilt Groupe.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.
Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.
› Verified 5 days ago
Carolyn Dienes, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1412 Butterfield Rd, Downers Grove, IL 60515 Phone: 630-627-3001 Fax: 630-627-3021 | |
Henna Asghar, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1402 Butterfield Rd, Butterfield Plaza, Downers Grove, IL 60515 Phone: 630-629-2025 | |
Hardesty Eye Care Associates Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3800 Highland Ave, Suite 100, Downers Grove, IL 60515 Phone: 630-960-0456 Fax: 630-960-9521 | |
Daniel James Deligio, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3450 Lacy Road, Downers Grove, IL 60515 Phone: 630-743-4500 | |
Dr. Alison Faye Stock, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2934 Finley Rd, Downers Grove, IL 60515 Phone: 630-916-4770 | |
Jessica Jose, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3450 Lacey Rd, Downers Grove, IL 60515 Phone: 630-743-4500 Fax: 630-743-4537 | |
Dr. Linda S Weil, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3800 Highland Ave, Ste. 100, Downers Grove, IL 60515 Phone: 630-960-0456 Fax: 630-960-9521 |